We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

199 hedge funds and large institutions have $912M invested in Editas Medicine in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $11.7M

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5.52% less ownership

Funds ownership: 89.21% → 83.69% (-5.5%)

13% less funds holding

Funds holding: 229 → 199 (-30)

33% less capital invested

Capital invested by funds: $1.35B → $912M (-$443M)

49% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 53

Holders
199
Holders Change
-30
Holders Change %
-13.1%
% of All Funds
4.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
69
Reduced
49
Closed
53
Calls
$21.1M
Puts
$11.7M
Net Calls
+$9.39M
Net Calls Change
+$6.7M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$22.4M
2
Renaissance Technologies
Renaissance Technologies
New York
+$5.52M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$4.78M
4
Victory Capital Management
Victory Capital Management
Texas
+$4.33M
5
NAMA
Nikko Asset Management Americas
New York
+$4.02M

Top Sellers

Rank Fund Capital Flow
1
VCM
Valiant Capital Management
California
-$11.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.23M
3
Morgan Stanley
Morgan Stanley
New York
-$9.22M
4
Deutsche Bank
Deutsche Bank
Germany
-$5.61M
5
Viking Global Investors
Viking Global Investors
Connecticut
-$5.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Manhattan
176
First Manhattan
New York
$3K +$5.04K +200 New
AA
177
Advisory Alpha
Michigan
$2.4K – – –
TCM
178
Tradewinds Capital Management
Washington
$2K -$858 -34 -25%
BWP
179
Baldwin Wealth Partners
Massachusetts
$2K – – –
FHA
180
Flagship Harbor Advisors
Massachusetts
$2K – – –
GC
181
Grace Capital
Massachusetts
$2K – – –
LF
182
Lee Financial
Texas
$2K – – –
NFG
183
Next Financial Group
Texas
$2K – – –
S
184
SignatureFD
Georgia
$2K – – –
SCA
185
Stonebridge Capital Advisors
Minnesota
$2K – – –
TFA
186
Toth Financial Advisory
Virginia
$2K – – –
SF
187
Synovus Financial
Georgia
$2K +$1.01K +40 +59%
SFS
188
Sowell Financial Services
Arkansas
$2K +$2.93K +116 New
GEA
189
Glen Eagle Advisors
New Jersey
$1.49K – – –
JPLA
190
Joseph P. Lucia & Associates
New York
$1K – – –
LC
191
Lindbrook Capital
California
$1K – – –
PAI
192
Pittenger & Anderson Inc
Nebraska
$1K – – –
EWP
193
Engrave Wealth Partners
Texas
$1K +$2.02K +80 New
ECM
194
Estabrook Capital Management
New York
$258 – – –
VCM
195
Valiant Capital Management
California
– -$11.2M -379,800 Closed
SEC
196
Seven Eight Capital
New York
– -$1.84M -62,300 Closed
Rafferty Asset Management
197
Rafferty Asset Management
New York
– -$1.46M -49,263 Closed
ARTA
198
A.R.T. Advisors
New York
– -$1.14M -38,479 Closed
CIC
199
Carnegie Investment Counsel
Ohio
– -$1.08M -36,590 Closed
Qube Research & Technologies (QRT)
200
Qube Research & Technologies (QRT)
United Kingdom
– -$1.07M -35,987 Closed
6 7
8
9 10

EDIT Hedge Fund Activity: Q1 2020 in Review

199 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2020, worth a combined $912M — down 33% from $1.35B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EDIT and 27 opened new positions — a net loss of 26 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was ARK Investment Management, adding an estimated $22.4M. The largest seller was Valiant Capital Management, exiting entirely with an estimated $11.2M sold.

  • 199 institutional investors held Editas Medicine (EDIT) as of Q1 2020, down from 229 in Q4 2019.
  • Funds reported $912M of Editas Medicine stock for Q1 2020, down 33% quarter-over-quarter.
  • 27 funds opened new Editas Medicine positions in Q1 2020 and 53 closed out, a net change of -26 holders.
  • The largest Editas Medicine buyer in Q1 2020 was ARK Investment Management, an estimated $22.4M added.
  • The largest Editas Medicine seller in Q1 2020 was Valiant Capital Management, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2020.